Cargando…
Aflibercept Treatment Leads to Vascular Abnormalization of the Choroidal Neovascularization
Recent studies do not support the hypothesis of vascular normalization in the eyes receiving various types of intravitreous antivascular endothelial growth factor (VEGF). This retrospective study considered 57 eyes of 32 patients with vascular age-related macular degeneration (AMD) undergoing aflibe...
Autores principales: | Wylęgała, Adam, Wylęgała, Filip, Wylęgała, Edward |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925136/ https://www.ncbi.nlm.nih.gov/pubmed/29850003 http://dx.doi.org/10.1155/2018/8595278 |
Ejemplares similares
-
The Effectiveness of Brolucizumab and Aflibercept in Patients with Neovascular Age-Related Macular Degeneration
por: Musiał-Kopiejka, Magdalena, et al.
Publicado: (2022) -
1-Year Fixed-Regimen Bevacizumab Treatment in DME-Vascular Network Image Analysis in Optical Coherence Tomography Angiography Study
por: Hunt, Magdalena, et al.
Publicado: (2022) -
Microcyclophotocoagulation in Glaucoma Treatment: A Medium-Term Follow-Up Study
por: Bolek, Bartłomiej, et al.
Publicado: (2023) -
Response to 1-Year Fixed-Regimen Bevacizumab Therapy in Treatment-Naïve DME Patients: Assessment by OCT Angiography
por: Hunt, Magdalena, et al.
Publicado: (2022) -
Assessment of Scleral and Conjunctival Thickness of the Eye after Ultrasound Ciliary Plasty
por: Bolek, Bartłomiej, et al.
Publicado: (2020)